Sort
48,018 grants matching “immunotherapy”
Actionable categories of avoidable hospital care among adults with cancer
$555,561Arthur Seokjae Hong · Ut Southwestern Medical Center · R01 · FY2024 · CA
1 of 3 Interdisciplinary Collaboratory for Enhancing Translational Therapeutics Utilizing Biologically, Immunologically, and Metabollically Relevant Models of Breast Cancer
$555,499William Joseph Murphy · University Of California At Davis · R01 · FY2017 · CA
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical Trial
$555,474Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2025 · CA
Restoring the Immunogenicity of Head and Neck Cancer
$555,467Yu Leo Lei · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · DE
ENGINEERING T CELLS AGAINST THE TUMOR EXTRACELLULAR MATRIX FOR ENHANCED IMMUNOTHERAPY OF MESOTHELIOMA
$555,447The Research Foundation For The State University Of New York · · FY2017 · Department of the Army
Regulation of memory T cell differentiation and long-term maintenance
$555,289Ananda W Goldrath · University Of Florida · P01 · FY2023 · AI
Defining post-transcriptional mechanisms that control CD8 T cell longevity, proliferation and differentiation
$555,221Leonid Pobezinskiy · University Of Massachusetts Amherst · R01 · FY2021 · AI
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$555,175Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2022 · CA
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
$555,172Mikhail Nikiforov · Duke University · R01 · FY2023 · CA
Clinical Fellowship Training Program
$555,067Peter Pinto · Division Of Basic Sciences - Nci · ZIE · FY2016 · CA
Imaging the effects of transcranial alternatingcurrent stimulation in an experimental model of Alzheimer's Disease
$555,058Bojana Stefanovic · Sunnybrook Research Institute · R01 · FY2024 · AG
Repurposing TRM for tumor immunotherapy
$554,986David Masopust · University Of Minnesota · R01 · FY2021 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$554,816William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2023 · CA
Chemotherapy and the Bladder Cancer Immune Microenvironment
$554,812William Y Kim · Univ Of North Carolina Chapel Hill · R01 · FY2022 · CA
Immunology And Pathology Of Acute and Chronic Murine Leukemia Virus Infections
$554,798Kim Hasenkrug · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Innate immune mechanisms of epithelial barrier disruption during treated HIV and SIV infections
$554,764Namita Rout · Tulane University Of Louisiana · R56 · FY2022 · DK
Optimized ex vivo expansion of anti-tumor Th1 and Tc1 for adoptive immunotherapy
$554,758Mary L. Disis · University Of Washington · R01 · FY2013 · CA
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$554,697Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2024 · AI
Defining the induction and maintenance of myelin-specific tolerance in T cells and B cells using local lymph node depots
$554,697Christopher M Jewell · Univ Of Maryland, College Park · R01 · FY2023 · AI
Molecular and Cellular Immunology
$554,564Jason G. Cyster · University Of California, San Francisco · T32 · FY2020 · AI
Correction of diabetic retinopathy by mitochondrial transfer
$554,407Denis A Proshlyakov · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2025 · EY
Characterizing and predicting colitis in immune checkpoint blockade-treated cancer patients
$554,399Sacha Gnjatic · Icahn School Of Medicine At Mount Sinai · U01 · FY2024 · DK
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2017 · CA
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2016 · CA
A Quantitative Multiplexed Platform for the Pharmacogenomic Analysis of Lung Cancer
$554,387Monte Meier Winslow · Stanford University · R01 · FY2018 · CA